These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 5115349)
1. [Parkinsonism and L-dopa: our 1st results]. Warot P; Petit H; Chevalier-Lefebvre J; Herbaut G Lille Med; 1971 May; 16(5):765-7. PubMed ID: 5115349 [No Abstract] [Full Text] [Related]
2. [Preliminary results of the treatment with L-Dopa of 30 patients with Parkinsonism]. Dumas R; Rahme M; Schott B J Med Lyon; 1971 Apr; 52(207):599-615. PubMed ID: 5136571 [No Abstract] [Full Text] [Related]
3. L-dopa and parkinsonism. Okihiro MM Hawaii Med J; 1971; 30(5):390-2. PubMed ID: 5160226 [No Abstract] [Full Text] [Related]
5. [Treatment of parkinsonism with L-dopa]. Hernández Peniche J; Martínez Villar C; De León Charles C Rev Invest Clin; 1971; 23(2):125-32. PubMed ID: 5114336 [No Abstract] [Full Text] [Related]
6. A hort-term evaluation of L-dopa therapy in 34 patients with parkinsonism. Mones RJ; Elizan TS J Mt Sinai Hosp N Y; 1969; 36(6):503-15. PubMed ID: 5261089 [No Abstract] [Full Text] [Related]
7. [Utility of L-dopa in the treatment of Parkinson's disease and parkinsonism-like diseases]. Herskovits E; Matera R; Gacitua EF Medicina (B Aires); 1972; 32(1):10-4. PubMed ID: 5019629 [No Abstract] [Full Text] [Related]
8. [Results of treatment of Parkinsonism with L-dopa]. De Divitiis E; D'Andrea F; Signorelli CD Sist Nerv; 1970; 22(2):99-108. PubMed ID: 5504563 [No Abstract] [Full Text] [Related]
9. L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism. Yahr MD; Duvoisin RC; Hoehn MM; Schear MJ; Barrett RE Trans Am Neurol Assoc; 1968; 93():56-63. PubMed ID: 4885744 [No Abstract] [Full Text] [Related]
10. L-DOPA treatment for Parkinsonism: analysis of functional improvement. Jonas S Arch Phys Med Rehabil; 1971 Dec; 52(12):560-2. PubMed ID: 5136441 [No Abstract] [Full Text] [Related]
11. [Clinical experience with L-DOPA in the treatment of parkinsonism]. Chiba T No To Shinkei; 1970 Dec; 22(12):1399-405. PubMed ID: 5536833 [No Abstract] [Full Text] [Related]
12. L-dopa: effect on highest integrative functions in Parkinsonism. Guthrie TC; Dunbar HS; Weider A Trans Am Neurol Assoc; 1970; 95():250-2. PubMed ID: 5514382 [No Abstract] [Full Text] [Related]
13. Quantitative analysis of the effects of L-dopa on gait in 26 patients with Parkinsonism. Peterson CR; Calvert JC; Canzoneri J; Leavitt LA; McCutchen JJ; Schwartz L Am J Phys Med; 1972 Aug; 51(4):171-81. PubMed ID: 5052844 [No Abstract] [Full Text] [Related]
14. [Neurophysiologic exploration of the parkinsonian syndromes treated with L-dopa. Technic and 1st results]. Mahoudeau D; Bathien N; Singer B; Bourdarias H; Renou G Rev Neurol (Paris); 1970 Dec; 123(6):453-7. PubMed ID: 5513753 [No Abstract] [Full Text] [Related]
15. The treatment of parkinsonism with L-Dopa and amantadine. Green J J Fla Med Assoc; 1970 Jun; 57(6):28-33. PubMed ID: 5445813 [No Abstract] [Full Text] [Related]
16. [Effects of L-dopa and stereotaxic surgery in Parkinsonism]. Sugita K; Mutsuga N; Takaoka Y; Takeda A No To Shinkei; 1970 Sep; 22(9):1103-8. PubMed ID: 4918927 [No Abstract] [Full Text] [Related]
17. [Clinical effect of L-DOPA and electromyographic study of Parkinsonism]. Sato G; Ito H; Handa Y; Takahashi I; Iijima K No To Shinkei; 1971 Mar; 23(3):325-32. PubMed ID: 5107821 [No Abstract] [Full Text] [Related]
18. [Toulouse-Piéron test in patients with Parkinsonism treated with L-dopa]. Megna GF; Puca FM; Leggiadro N; Micalizzi V; Pigneri MT Acta Neurol (Napoli); 1973; 28(2):213-22. PubMed ID: 4575429 [No Abstract] [Full Text] [Related]
19. [Treatment of parkinsonism with L-dopa]. Presthus J Nord Med; 1970 Nov; 84(46):1467-8. PubMed ID: 5479940 [No Abstract] [Full Text] [Related]